Broadcom Inc (AVGO) Stock Price Today
Aura AI Summary
Key Stats
- $1.76TMARKET_CAP
- -VOLUME
- TechnologySECTOR
- $481.57FIFTY_TWO_WEEK_HIGH
- $271.80FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $1.81TENTERPRISE_VALUE
- 0.7%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Broadcom Inc (AVGO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Broadcom Inc has traded between a low of $271.8 and a high of $481.57, highlighting its annual price range. Buy and sell Broadcom Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Broadcom Inc
Broadcom--the combined entity of Broadcom and Avago--boasts a highly diverse product portfolio across an array of end markets. Avago focused primarily on radio frequency filters and amplifiers used in high-end smartphones, such as the Apple iPhone and Samsung Galaxy devices, in addition to an assortment of solutions for wired infrastructure, enterprise storage, and industrial end markets. Legacy Broadcom targeted networking semiconductors, such as switch and physical layer chips, broadband products (such as television set-top box processors), and connectivity chips that handle standards such as Wi-Fi and Bluetooth. The company has acquired Brocade, CA Technologies, Symantec's enterprise security business, and has a pending deal to acquire VMware to bolster its offerings in software.
Most Recent News
Quest Software achieves FedRAMP High certification for identity security in AI-driven threat era
Quest Software has obtained FedRAMP High authorization for its Quest Identity Defense and Quest Identity Recovery products on Microsoft Azure Government, making it the only provider with a FedRAMP High SaaS offering for hybrid Active Directory and Mi...
Cannabix and Omega launch breath test panel detecting recent use of multiple drugs like DOT urine tests.
Cannabix Technologies and Omega Laboratories have developed a breath-based drug testing panel that detects recent use of multiple drug classes, modeled after the federally mandated DOT urine drug test panel. This new breath test can identify amphetam...
Blue Origin raises $10B in first funding round, valuing the company at $130B
Jeff Bezos' space company Blue Origin is raising about $10 billion in its first external funding round, valuing the company at $130 billion. Bezos plans to invest $2 billion, with hedge fund Coatue Management contributing $4 billion. The remaining $4...